Helmholtz Zentrum München is a research center with the mission to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world.
Short biography principal investigator
Prof. Dr. Heiko Lickert
Heiko Lickert obtained his PhD in Biology from the University of Freiburg and his PhD and Postdoctoral studies were carried out in the laboratory of Prof. Rolf Kemler at the Max Planck Institute in Freiburg and in the laboratory of Prof. Janet Rossant at the Mount Sinai Hospital, Toronto, Canada.
Currently he is a W3 Professor and Chair of Beta Cell Biology in the Medical Faculty of the Technical University Munich, the Director of the Institute of Diabetes and Regeneration Research and Principal Investigator in the Institute of Stem Cell Research at the Helmholtz Center Munich. He is also in the Steering Committee of the Helmholtz Diabetes Center, the Helmholtz Pioneer Campus and in the Research Coordination Board of the German Center for Diabetes Research. His work has been funded by the European Research Council and an Emmy-Noether fellowship from the German Research Foundation.
Key Research Facility and Equipment
Core Facilities are centralized shared units that provide access to services for scientific and clinical investigators and recover a portion of their costs in the form of user fees.